Chronic kidney Disease overall survival prediction model based on frailty index score: construction and validation using NHANES data

基于衰弱指数评分的慢性肾脏病总体生存预测模型:利用NHANES数据构建和验证

阅读:1

Abstract

BACKGROUND: Frailty predicts poor outcomes in chronic kidney disease (CKD) patients. This study compared frailty's predictive power with other factors and aimed to develop a model for predicting overall survival (OS) in CKD patients. METHODS: The study included 3,714 CKD participants from the National Health and Nutrition Examination Survey 2005-2018. The death data were updated to December 31, 2019. Lasso-Cox regression identified significant predictors among 42 factors, resulting in a prognostic nomogram using 11 key variables. Subsequent evaluation of the nomogram involved the C-index, the Areas Under Time-dependent Receiver Operating Characteristic Curves (AUC) and calibration curves. RESULTS: Over a median follow-up of 5.92 years, 1,234 deaths occurred. The final predictors of OS in CKD patients included age, ethnicity, smoking status, estimated pulse wave velocity, body fat percentage, blood uric acid concentration, blood urea nitrogen concentration, and albumin concentration, neutrophil-to-lymphocyte ratio, urine albumin-to-creatinine ratio level, and frailty index (FI) score. The FI score was the strongest predictor with an HR of 76.54 (95% CI: 42.93, 136.46, p < 0.0001). In the training set, the AUC values were 80.11% for 1-year, 79.90% for 3-year, 79.53% for 5-year, and 81.34% for 10-year follow-ups. In the internal validation set, AUC values were 78.66%, 77.78%, 77.56%, and 79.54%, respectively. The nomogram's corrected C-index was 0.76 (95% CI: 0.75 - 0.78), and calibration curves showed satisfactory accuracy. CONCLUSIONS: The FI score is a significant predictor of CKD OS. The developed nomogram based on the FI score is a promising tool for predicting the OS of CKD patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。